| Vicky J Griffin, DO | |
|
1151 Marguerite St, Morgan City, LA 70380-1850 | |
| (985) 221-4400 | |
| (985) 221-4404 |
| Full Name | Vicky J Griffin |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 1151 Marguerite St, Morgan City, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619952900 | NPI | - | NPPES |
| A341 | Other | FL | HEALTH FIRST NETWORK |
| 59155862 | Other | AL | BLUE CROSS BLUE SHIELD |
| 44674 | Other | FL | BLUE CROSS BLUE SHIELD |
| 160043622 | Other | FL | MEDICARE RAILROAD |
| 255327900 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | OS7118 (Florida) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 301024 (Louisiana) | Primary |
| Entity Name | Gulf Health Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134164924 PECOS PAC ID: 3375448491 Enrollment ID: O20110208000622 |
News Archive
GE is helping to transform the delivery of patient care with Venue™ 40, a miniaturized ultrasound system with advanced touch-screen technology, launched by GE Healthcare, a business unit of General Electric Company. Venue 40 is portable, allowing physicians to quickly perform rapid diagnostics and needle-guided procedures right at a patient's bedside, providing real-time results.
Some chemical alternatives to plastic bisphenol-a (BPA), which is still commonly used in medical settings such as operating rooms and intensive care units, may be less disruptive to heart electrical function than BPA, according to a pre-clinical study that explored how the structural analogues bisphenol-s (BPS) and bisphenol-f (BPF) interact with the chemical and electrical functions of heart cells.
Angiotech Pharmaceuticals, Inc. today announced that the affected creditors of Angiotech and certain of its subsidiaries (collectively, the "Angiotech Entities") have unanimously approved the Second Amended and Restated Plan of Compromise or Arrangement concerning, affecting and involving the Angiotech Entities pursuant to the Companies' Creditors Arrangement Act (Canada).
Despite great hopes for stem cell therapy, major structural and cultural changes within the NHS are needed if it is to succeed in the UK. Currently the chances of getting effective treatments into routine use in the short-term are small and the industry is at serious risk of 'market failure'.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and NuPathe Inc., a neuroscience-focused specialty pharmaceutical company, announced today that the companies have entered into a license agreement for drug delivery technology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vicky J Griffin, DO 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 | Vicky J Griffin, DO 1151 Marguerite St, Morgan City, LA 70380-1850 Ph: (985) 221-4400 |
News Archive
GE is helping to transform the delivery of patient care with Venue™ 40, a miniaturized ultrasound system with advanced touch-screen technology, launched by GE Healthcare, a business unit of General Electric Company. Venue 40 is portable, allowing physicians to quickly perform rapid diagnostics and needle-guided procedures right at a patient's bedside, providing real-time results.
Some chemical alternatives to plastic bisphenol-a (BPA), which is still commonly used in medical settings such as operating rooms and intensive care units, may be less disruptive to heart electrical function than BPA, according to a pre-clinical study that explored how the structural analogues bisphenol-s (BPS) and bisphenol-f (BPF) interact with the chemical and electrical functions of heart cells.
Angiotech Pharmaceuticals, Inc. today announced that the affected creditors of Angiotech and certain of its subsidiaries (collectively, the "Angiotech Entities") have unanimously approved the Second Amended and Restated Plan of Compromise or Arrangement concerning, affecting and involving the Angiotech Entities pursuant to the Companies' Creditors Arrangement Act (Canada).
Despite great hopes for stem cell therapy, major structural and cultural changes within the NHS are needed if it is to succeed in the UK. Currently the chances of getting effective treatments into routine use in the short-term are small and the industry is at serious risk of 'market failure'.
SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry, and NuPathe Inc., a neuroscience-focused specialty pharmaceutical company, announced today that the companies have entered into a license agreement for drug delivery technology.
› Verified 4 days ago
Dr. Julie E. S. Price, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1151 Marguerite St, Suite 700a, Morgan City, LA 70380 Phone: 985-221-4400 Fax: 985-221-4404 | |
Dr. Natchez Joseph Morice Iii, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1216 N Victor Ii Blvd, Suite 100, Morgan City, LA 70380 Phone: 985-702-2229 Fax: 985-384-0329 | |
Elizabeth Holt Zabel, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1216 N Victor Ii Blvd, Suite 100, Morgan City, LA 70380 Phone: 985-702-2229 Fax: 985-384-0329 | |
Nsikan St Martin, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 215 Everett St, Morgan City, LA 70380 Phone: 985-354-6081 |